Skip to content
Screener

Enovix Corporation ENVX Cash & Equivalents

Cash & Equivalents at other companies

KULR Technology Group logo
KULR Technology GroupKULR
$7.68M-68.6%
QuantumScape Corporation logo
QuantumScape CorporationQS
$145.07M-5.5%
Solidion Technology, Inc. logo
Solidion Technology, Inc.STI
$27.68M+6,016,708%
Amprius Technologies logo
Amprius TechnologiesAMPX
$74.77M+34.4%
SLD
Solid PowerSLDP
$24.28M-7.5%
NeoVolta logo
NeoVoltaNEOV
$11.48M+2,042%

Other financials

Income statement

See full
Revenue$7.6M+49.1%
Gross profit$1.6M+495%
Operating income-$43.9M-3.1%
Net income-$38.3M-62.7%
EPS (diluted)-$0.18-50.0%

Balance sheet

See full
Total debt$543.6M+179%
Total equity$240.7M+2.4%
Total assets$833.9M+67.1%

Cash flow

See full
Operating cash flow-$33.1M-95.6%
CapEx$3.2M-48.7%
Free cash flow-$36.3M-56.6%

Valuation

See full
Market cap$929.33M-57.9%
Enterprise value$1.38B-39.0%
P/S27.1×-55.9×

Profitability

See full
Gross margin21.5%
Operating margin-520.3%-160pp
Net margin-499.6%-149pp
FCF margin-368.9%-117pp

Returns & leverage

See full
Return on equity-72.1%-10.0pp
Debt / equity2.3×+1.4×
Current ratio11×+6.3×

Where this comes from

Reported directly by Enovix Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Enovix Corporation’s 10-Q, filed May 14, 2026.

Filed
May 13, 2026, 8:00 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001828318-26-000029
Line itemFiscal Quarters Ended / April 5,2026Fiscal Quarters Ended / March 30,2025
Repayment of debt(55)
Proceeds from the exercise of stock options782
Payments of transaction costs related to common stock issuance(512)
Net cash used in financing activities(2,458)(1,491)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(147)(228)
Change in cash, cash equivalents, and restricted cash(17,347)(82,997)
Cash and cash equivalents and restricted cash, beginning of period107,979274,691
Cash and cash equivalents and restricted cash, end of period$90,632$191,694

Item 1. Financial Statements (unaudited)

FAQ

What is Enovix Corporation's cash & equivalents?
Enovix Corporation (ENVX) reported cash & equivalents of $90.63M in Q1 2026.
How has Enovix Corporation's cash & equivalents changed year-over-year?
Enovix Corporation's cash & equivalents decreased by 52.7% year-over-year, from $191.69M to $90.63M.
What is the long-term trend for Enovix Corporation's cash & equivalents?
Over 5 years (2020 to 2025), Enovix Corporation's cash & equivalents has grown at a 29.9% compound annual growth rate (CAGR), from $29.22M to $107.98M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Enovix Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude